MemPsych Biotech to Showcase Revolutionary Memory Enhancement Innovation at BIO Asia-Taiwan 2025, Asia's Premier Biotech Event

Cincinnati, OH — July 16th, 2025 – MemPsych Biotech, a revenue-generating leader in neuroscience-focused biotechnology, announced today its selection as one of a select group of emerging companies invited to present at BIO Asia–Taiwan 2025, the premier biotechnology exhibition and conference in Asia.
MemPsych will present its cornerstone product, Memfocus™, which contains Psychlomin™, chemically known as 6-MSITC. An independent double-blinded randomized controlled clinical trial showed 6-MSITC to achieve an 18% increase in episodic memory after nearly 90 days of dosing in a population of 60 years of age and older.
The prestigious event will be held July 23–27, 2025, at the Nangang Exhibition Center (TaiNEX 1 & 2) in Taipei, bringing together global biotechnology industry leaders, investors, and innovators to explore transformative opportunities shaping the future of biotech.
MemPsych Biotech’s selection underscores the Company’s groundbreaking contributions to cognitive health, most notably through its solutions addressing memory, mental clarity, and age-related neurological decline.
"We are honored to be recognized among the world’s most innovative biotech companies," said Jason E. Barkeloo, Founder and CEO of MemPsych Biotech. "BIO Asia–Taiwan is a unique platform to share our vision for a new era of neuroscience-driven therapeutics and dietary supplements. It also gives us an opportunity to forge strategic partnerships to distribute our Memfocus solution and in-license other solutions.
MemPsych Biotech’s presentation on July 25th, 2025, at 16:00, will spotlight its memory support technology and outline the Company’s commercialization strategy. The goal is to show the Company’s focus to meet the growing global demand for science-based solutions that address the urgent challenges of memory and cognitive decline.

About MemPsych Biotech
MemPsych Biotech is dedicated to redefining cognitive wellness through rigorous science and innovative product development. The Company’s flagship solutions leverage advanced neurobiology and natural bioactive compounds to enhance memory, focus, and overall brain health. The Company intends to couple its memory support product with an artificial intelligence (AI) solution to further increase memory support. With a commitment to evidence-based innovation and global accessibility, MemPsych Biotech is at the forefront of a movement to transform how the world approaches mental performance and healthy aging.

Visit MemPsych Biotech and its Memfocus products at:

MemPsych Biotech
Amazon
LinkedIn

For partnership and media inquiries, or to schedule a meeting during the event, please contact:
Media Contact:
MemPsych Biotech
PO Box 30085
Cincinnati, OH 45230
USA
Contact: Jason E. Barkeloo, Founder
info@mempsych.bio
https://Memfocus.com

This release was published on openPR.